Schott Pharma AG KGaA (XTER:1SXP) FCF Margin % : 0.68% (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Schott Pharma AG KGaA's Free Cash Flow for the six months ended in Sep. 2023 was €6.1 Mil. Schott Pharma AG KGaA's Revenue for the six months ended in Sep. 2023 was €898.6 Mil. Therefore, Schott Pharma AG KGaA's FCF Margin % for the quarter that ended in Sep. 2023 was 0.68%.

As of today, Schott Pharma AG KGaA's current FCF Yield % is 0.14%.

The historical rank and industry rank for Schott Pharma AG KGaA's FCF Margin % or its related term are showing as below:

XTER:1SXP' s FCF Margin % Range Over the Past 10 Years
Min: 0.68 Med: 3.43 Max: 5.18
Current: 0.68

During the past 4 years, the highest FCF Margin % of Schott Pharma AG KGaA was 5.18%. The lowest was 0.68%. And the median was 3.43%.

XTER:1SXP's FCF Margin % is ranked better than
61.52% of 829 companies
in the Medical Devices & Instruments industry
Industry Median: -7.14 vs XTER:1SXP: 0.68

Schott Pharma AG KGaA FCF Margin % Historical Data

The historical data trend for Schott Pharma AG KGaA's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA FCF Margin % Chart

Schott Pharma AG KGaA Annual Data

Trend

Sep20

Sep21

Sep22

Sep23

FCF Margin %

3.27

5.18

3.58

0.68

Schott Pharma AG KGaA Semi-Annual Data
	Sep20	Sep21	Sep22	Sep23
FCF Margin %	3.27	5.18	3.58	0.68

Competitive Comparison of Schott Pharma AG KGaA's FCF Margin %

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Schott Pharma AG KGaA's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's FCF Margin % falls into.

Schott Pharma AG KGaA FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Schott Pharma AG KGaA's FCF Margin for the fiscal year that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Sep. 2023 )	/	Revenue (A: Sep. 2023 )
	=	6.128	/	898.602
	=	0.68 %

Schott Pharma AG KGaA's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	6.128	/	898.602
	=	0.68 %

Schott Pharma AG KGaA FCF Margin % Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Schott Pharma AG KGaA (XTER:1SXP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (XTER:1SXP) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

1SXP:Austria

Address

Hattenbergstraße 10, Mainz, DEU, 55122

Website

https://www.schott-pharma.com

Schott Pharma AG & CO KGaA is a multinational glass company specializing in the manufacture of glass and glass ceramics. It is represented in 34 countries and serves a multitude of industries from Healthcare, Home Appliances and living, and Consumer Electronics to Semiconductors and datacom, Optics, Industry and energy, Automotive, and Astronomy and aerospace.

Executives

Andreas Reisse	Board of Directors
Ann-kristin Erkens	Supervisory Board
Dr. Almuth Steinkühler	Board of Directors
Dr. Jens Schulte	Supervisory Board
Dr. Wolfgang Wienand	Supervisory Board
Peter Goldschmidt	Supervisory Board

Schott Pharma AG KGaA (XTER:1SXP) Headlines

No Headlines